Back to search

France· FR:69024085

ALFENTANIL KALCEKS 0,5 mg/mL, solution injectable/pour perfusion

A alfentanil product containing chlorhydrate d'alfentanil, registered in France by AS KALCEKS (LETTONIE). The same ATC class is registered in 12 of our 19 countries.

ATC N01AH02

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedALFENTANIL KALCEKS 0,5 mg/mL, solutio…ATCN01AH02REGISTER NO.FR:69024085PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Alfentanil is registered in 12 of 19 countries.

Countries holding a registration under ATC N01AH02 (alfentanil), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 6 of them publish a price we can compare per daily dose

Alfentanil · ATC N01AH02

12 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
CHLORHYDRATE D'ALFENTANIL
Manufacturer
AS KALCEKS (LETTONIE)
Country
France (FR)
ATC code
N01AH02
ATC class
Alfentanil
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

  • cip13
    3400955068099
    10 ampoule(s) en verre de 2 ml
  • cip13
    3400955068112
    5 ampoule(s) en verre de 10 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

240 interactions on record for alfentanil.

Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Alfentanil · interactions on record

240 records

  • 41 severe
  • 163 moderate
  • 2 minor
  • 34 info

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Alfentanil in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alfentanil products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Alfentanil Hameln, Rapifen
  • Belgium · Alfentanil Kalceks, Rapifen
  • Czechia · Rapifen
  • Germany · Alfentanil Hameln, Alfentanil Kalceks
  • Denmark · Alfentanil Hameln, Alfentanil Kalceks
  • Spain · Limifen
  • Finland · Alfentanil Hameln, Alfentanil Kalceks
  • United Kingdom (Northern Ireland) · Alfentanil Hameln, Alfentanil Hameln Pharma
  • Ireland · Rapifen
  • Italy · Alfentanil Piramal
  • Luxembourg · Rapifen
  • Latvia · Alfentanil Kalceks
  • Malta · Alfentanil Kalceks
  • Netherlands · Alfentanil Hameln, Alfentanil Kalceks
  • Norway · Alfentanil Hameln, Alfentanil Kalceks
  • Portugal · Alfentanilo Hameln, Alfentanilo Kalceks
  • Sweden · Alfentanil Hameln, Alfentanil Kalceks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/62489024-b80b-46ac-a6f9-374324f1d631
GET /v1/drugs/62489024-b80b-46ac-a6f9-374324f1d631?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69024085",
  "date_amm": "2019-07-31",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "CHLORHYDRATE D'ALFENTANIL",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable ou pour perfusion",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about alfentanil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.